Medicare Enrolled

Dr. Dipti Doshi, MD

Rheumatology · Cerritos, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
17100 NORWALK BLVD, Cerritos, CA 90703
5628602111
In practice since 2006 (19 years)
NPI: 1053325761 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Doshi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Doshi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Doshi

Dr. Dipti Doshi is a rheumatology specialist in Cerritos, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Doshi performed 2,309 Medicare services across 747 unique beneficiaries.

Between the years covered by Open Payments, Dr. Doshi received a total of $55,480 from 23 pharmaceutical and/or device companies across 185 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Doshi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 35% volume in CA $55,480 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,309
Medicare services
Top 35% in CA for rheumatology
747
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~122 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
750 $150 $300
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
571 $1 $60
Ketorolac injection, per 15 mg
An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg.
344 $0 $50
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
173 $12 $42
Visual field test, limited
A test that measures your side (peripheral) vision. This limited version assesses a restricted portion of your visual field.
106 $30 $130
Hearing test for various pitches
A hearing test that measures the ability to hear different sound frequencies using earphones.
96 $33 $130
New patient office visit, complex (60-74 min) 89 $160 $374
Trigger point injection, 3 or more muscles
Injection of medication into three or more specific muscle trigger points to relieve pain.
81 $53 $575
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
43 $84 $187
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
28 $101 $240
Complete ultrasound scan of joint
An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures.
28 $42 $300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$55,480
Total received (2018-2024)
Avg $7,926/year across 7 years
Top 11% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
185
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$44,530 (80.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,592 (15.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,359 (4.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$7,636
2023
$1,089
2022
$216
2021
$1,056
2020
$5,067
2019
$13,314
2018
$27,102

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$7,292
Amgen Inc.
$110
PFIZER INC.
$69
Aurinia Pharma U.S., Inc.
$63
ABBVIE INC.
$41
Kiniksa Pharmaceuticals International, plc
$21
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
UCB, Inc.
$20
Top 3 companies account for 97.8% of 2024 payments
All-time payments by company (2018-2024) ›
Horizon Pharma plc
$26,770
Horizon Therapeutics plc
$17,804
GlaxoSmithKline, LLC.
$8,201
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,320
PFIZER INC.
$300
Amgen Inc.
$291
Aurinia Pharma U.S., Inc.
$108
AbbVie, Inc.
$106
Novartis Pharmaceuticals Corporation
$89
ABBVIE INC.
$87
AbbVie Inc.
$60
AstraZeneca Pharmaceuticals LP
$54
Radius Health, Inc.
$47
Kaleo, Inc.
$46
Fresenius Kabi USA, LLC
$30
Celgene Corporation
$24
Alexion Pharmaceuticals, Inc.
$23
Mallinckrodt Enterprises LLC
$22
Kiniksa Pharmaceuticals International, plc
$21
Gilead Sciences, Inc.
$21
FIDIA PHARMA USA INC.
$20
UCB, Inc.
$20
GENZYME CORPORATION
$16
Top 3 companies account for 95.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Arcalyst · BENLYSTA · COSENTYX · Cimzia · ELIQUIS · EVENITY · EVUSHELD · EVZIO · Enbrel · HYALGAN · Humira · IDACIO · KEVZARA · KRYSTEXXA · LUPKYNIS · OFEV · Otezla · RAYOS · RINVOQ · Rinvoq · SAPHNELO · Strensiq · TAVNEOS · Tymlos · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (80%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware.

Looking for a rheumatology specialist in Cerritos?
Compare rheumatologists in the Cerritos area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
196
Per 100K population
2.0
County median income
$87,760
Nearest hospital
COLLEGE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Doshi is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 11% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Doshi experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Doshi performed 750 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Doshi receive payments from pharmaceutical companies?
Yes. Dr. Doshi received a total of $55,480 from 23 companies across 185 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Doshi's costs compare to other rheumatologists in Cerritos?
Dr. Doshi's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Doshi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →